Authors
Adrian Toutoungi

Adrian Toutoungi

Partner

Read More
josef fuss

Josef Fuss

Partner

Read More
Authors
Adrian Toutoungi

Adrian Toutoungi

Partner

Read More
josef fuss

Josef Fuss

Partner

Read More

23 June 2020

Venture-backed biotech companies – 2 of 2 Insights

Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow

  • IN-DEPTH ANALYSIS
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

White microscope on yellow background
Life sciences & healthcare

Biotech acquisition trend: radiopharmaceuticals

8 May 2024
Briefing

by Adrian Toutoungi

Click here to find out more
Patterned pills
Life sciences & healthcare

Edison Open House Global Healthcare 2021 – key takeaways from our panel

4 February 2021
Quick read

by multiple authors

Click here to find out more
scientist-with-vials
Life sciences & healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues

22 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Josef Fuss

Click here to find out more